As head of the U.S. bishops’ Laity, Marriage, Family Life, and Youth Committee, Bishop Barron decried the FDA’s latest action as a violation of the Hippocratic Oath.
The U.S. bishops have long advocated against FDA nonprescription approval of Opill because of potential harmful side effects.